Aside from the traditional Aβ and tau hypotheses, the first link between neuroinflammation and AD pathogenesis was supported by the genetic mutation of triggering receptors expressed on myeloid cells 2 (TREM2) of microglia [18]. This evidence concerns the gene MAPT and Alzheimer disease.